- Conditions
- Drug Toxicity Psychotropic Agents Psychostimulants
- Interventions
- Ryanodex (dantrolene sodium) for injectable suspension
- Drug
- Lead sponsor
- Eagle Pharmaceuticals, Inc.
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 2 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2017 – 2018
- U.S. locations
- 1
- States / cities
- Baltimore, Maryland
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1–5
of 5
matching trials from the live ClinicalTrials.gov search.
- Conditions
- Cancer Which Has Either Progressed or Relapsed After Standard Therapy, or for Which no Curative or Standard Therapy is Appropriate
- Interventions
- Test Product (Bendamustine)
- Drug
- Lead sponsor
- Eagle Pharmaceuticals, Inc.
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 81 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2013 – 2014
- U.S. locations
- 10
- States / cities
- Long Beach, California • Wichita, Kansas • Cherry Hill, New Jersey + 7 more
- Conditions
- Pharmacokinetics
- Interventions
- Fulvestrant for Injectable Suspension, Faslodex (Reference)
- Drug
- Lead sponsor
- Eagle Pharmaceuticals, Inc.
- Industry
- Eligibility
- 40 Years to 75 Years · Female only
- Enrollment
- 600 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2017 – 2018
- U.S. locations
- 12
- States / cities
- Long Beach, California • DeLand, Florida • Miami, Florida + 7 more
- Conditions
- Pneumonia, Bacterial
- Interventions
- CAL02, Placebo
- Drug
- Lead sponsor
- Eagle Pharmaceuticals, Inc.
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 276 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2023 – 2026
- U.S. locations
- 7
- States / cities
- Fresno, California • Gainesville, Florida • Chicago, Illinois + 4 more
- Conditions
- Cataract Surgery Anesthesia
- Interventions
- Arm 1 Cataract Surgery performed with remimazolam as sedative, Arm 2 Cataract Surgery performed with standard of care sedative
- Drug
- Lead sponsor
- Fred E, Shapiro
- Other
- Eligibility
- 55 Years to 90 Years
- Enrollment
- 30 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2026 – 2028
- U.S. locations
- 1
- States / cities
- Boston, Massachusetts